Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VitalStar is a China-based biotechnology company focused on genetically modified, humanized, and disease-model rodents for biomedical research and preclinical evaluation. Founded in 2000, the company provides custom model generation, breeding and colony management, embryology and microbiology services, transplantation studies, and in vivo pharmacology support for small molecules, biologics, and cell and gene therapies. Its offerings include immunodeficient and humanized mouse strains such as NPG mice, tumor and metabolic disease models, and liver-humanized systems for hepatitis research and antiviral drug screening. Rather than advancing a proprietary therapeutic drug pipeline, VitalStar operates as a research-tools and services company supporting pharmaceutical, biotech, and academic customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VitalStar.